Hunter Associates Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.31M Sell
41,519
-242
-0.6% -$60.3K 1.23% 16
2025
Q4
$10M Sell
41,761
-371
-0.9% -$94.9K 1.34% 16
2025
Q3
$11.5M Sell
42,132
-1,485
-3% -$406K 1.6% 13
2025
Q2
$11.3M Sell
43,617
-6,618
-13% -$1.58M 1.67% 13
2025
Q1
$11.3M Buy
50,235
+400
+0.8% +$93.4K 1.74% 11
2024
Q4
$11.4M Sell
49,835
-530
-1% -$128K 1.74% 13
2024
Q3
$12.3M Buy
50,365
+70
+0.1% +$15.6K 1.9% 10
2024
Q2
$9.63M Sell
50,295
-400
-0.8% -$81.2K 1.62% 12
2024
Q1
$10.1M Buy
50,695
+307
+0.6% +$56.3K 1.69% 11
2023
Q4
$8.67M Sell
50,388
-908
-2% -$140K 1.59% 12
2023
Q3
$7.59M Buy
51,296
+2,505
+5% +$453K 1.54% 16
2023
Q2
$10.7M Sell
48,791
-1,645
-3% -$367K 2.09% 7
2023
Q1
$11M Sell
50,436
-3,415
-6% -$741K 2.37% 5
2022
Q4
$11.2M Sell
53,851
-215
-0.4% -$47.2K 2.7% 5
2022
Q3
$11.8M Sell
54,066
-681
-1% -$155K 3.06% 4
2022
Q2
$11.5M Buy
54,747
+18,318
+50% +$3.9M 2.83% 4
2022
Q1
$8.83M Sell
36,429
-2,800
-7% -$677K 2.84% 8
2021
Q4
$10.2M Buy
39,229
+2,000
+5% +$519K 2.92% 7
2021
Q3
$9.81M Sell
37,229
-1,300
-3% -$355K 3.15% 7
2021
Q2
$9.5M Sell
38,529
-25,889
-40% -$5.44M 2.96% 7
2021
Q1
$12.5M Sell
64,418
-531
-0.8% -$106K 2.89% 7
2020
Q4
$13.8M Sell
64,949
-2,190
-3% -$437K 3.4% 5
2020
Q3
$11.5M Sell
67,139
-3,195
-5% -$590K 3.2% 5
2020
Q2
$13.5M Buy
70,334
+3,944
+6% +$645K 4.01% 4
2020
Q1
$9.78M Sell
66,390
-2,738
-4% -$436K 3.79% 4
2019
Q4
$10.7M Sell
69,128
-1,965
-3% -$283K 3.33% 5
2019
Q3
$9.61M Sell
71,093
-5,909
-8% -$774K 3.3% 5
2019
Q2
$9.4M Sell
77,002
-400
-0.5% -$44.3K 3.23% 5
2019
Q1
$8.05M Buy
77,402
+935
+1% +$96.5K 2.82% 8
2018
Q4
$8.71M Sell
76,467
-640
-0.8% -$68.6K 3.54% 4
2018
Q3
$8.89M Sell
77,107
-450
-0.6% -$49.3K 3.07% 7
2018
Q2
$8.03M Sell
77,557
-320
-0.4% -$32.4K 2.9% 7
2018
Q1
$7.67M Buy
77,877
+289
+0.4% +$27.3K 2.86% 7
2017
Q4
$6.57M Sell
77,588
-860
-1% -$71K 2.42% 9
2017
Q3
$6.04M Sell
78,448
-290
-0.4% -$22.2K 2.35% 9
2017
Q2
$6.13M Sell
78,738
-413
-0.5% -$29.5K 2.49% 8
2017
Q1
$5.7M Sell
79,151
-600
-0.8% -$41.5K 2.4% 8
2016
Q4
$4.95M Sell
79,751
-865
-1% -$53K 2.11% 14
2016
Q3
$5.22M Sell
80,616
-2,731
-3% -$182K 2.24% 8
2016
Q2
$5.27M Buy
83,347
+17
+0% +$1K 2.28% 10
2016
Q1
$4.82M Sell
83,330
-365
-0.4% -$20.7K 2.2% 11
2015
Q4
$4.49M Sell
83,695
-2,200
-3% -$124K 1.97% 13
2015
Q3
$4.38M Sell
85,895
-3,550
-4% -$191K 2.05% 12
2015
Q2
$5.04M Sell
89,445
-5,675
-6% -$358K 2.1% 11
2015
Q1
$6.83M Sell
95,120
-950
-1% -$61.7K 2.69% 7
2014
Q4
$5.39M Sell
96,070
-550
-0.6% -$28.7K 2.07% 8
2014
Q3
$4.76M Buy
96,620
+350
+0.4% +$17.8K 1.86% 12
2014
Q2
$4.87M Buy
96,270
+1,800
+2% +$89.2K 1.92% 10
2014
Q1
$4.22M Buy
94,470
+750
+0.8% +$33.7K 1.67% 14
2013
Q4
$4.41M Buy
93,720
+18,725
+25% +$948K 1.7% 13
2013
Q3
$3.96M Sell
74,995
-12,220
-14% -$593K 1.65% 13
2013
Q2
$3.94M Buy
+87,215
New +$4.14M 1.46% 17

Other funds holding RMD

Hunter Associates Investment Management's RMD Position: Q1 2026 in Review

Hunter Associates Investment Management reduced its ResMed (RMD) stake by 0.58% in Q1 2026, selling an estimated $60.3K and leaving 41,519 shares worth $9.31M. The position accounts for 1.23% of the portfolio, ranked #16.

Hunter Associates Investment Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.8M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Hunter Associates Investment Management held 41,519 shares of ResMed worth $9.31M as of Q1 2026.
  • Hunter Associates Investment Management sold 242 ResMed shares in Q1 2026, an estimated $60.3K.
  • ResMed made up 1.23% of Hunter Associates Investment Management's portfolio in Q1 2026, its #16 holding.
  • Hunter Associates Investment Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Hunter Associates Investment Management's ResMed position peaked at $13.8M in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Hunter Associates Investment Management's 13F filing for Q1 2026, filed 27 Apr 2026.